Dr. Schwartz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
420 East First Street
Duluth, MN 55801Phone+1 218-786-1311
Summary
- Dr. David Schwartz is a Radiation Oncologist based in Duluth, MN. He earned his B.S. in Biology and Chemistry from Emory University and completed his medical degree and residency in Radiation Oncology at Mayo Clinic College of Medicine. He is currently Enterprise Section Chair of Radiation Oncology for Essentia Health, based in Duluth, Minnesota. His areas of expertise include breast cancer, prostate cancer, head and neck radiation oncology, and thoracic radiation oncology. Dr. Schwartz has authored several impactful studies, some of which have been widely cited in prominent journals such as the International Journal of Radiation Oncology, Biology, Physics.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 2003 - 2007
- Mayo Clinic College of Medicine and ScienceInternship, Transitional Year, 2002 - 2003
- Mayo Clinic College of MedicineClass of 2002
- Emory UniversityB.S., Biology and Chemistry, 1994 - 1998
Certifications & Licensure
- MN State Medical License 2003 - 2025
- ND State Medical License 2023 - 2025
- WI State Medical License 2005 - 2025
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 99 citationsMometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Ca...Robert C. Miller, David Schwartz, Jeff A. Sloan, Patricia C. Griffin, Richard L. Deming
International Journal of Radiation Oncology, Biology, Physics. 2011-04-01 - 48 citationsComparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast ...Michelle A. Neben-Wittich, Pamela J. Atherton, David Schwartz, Jeff A. Sloan, Patricia C. Griffin
International Journal of Radiation Oncology, Biology, Physics. 2009-11-01 - 16 citationsPrediction of Radial Distance of Extraprostatic Extension From Pretherapy FactorsDavid Schwartz, Shomik Sengupta, David W. Hillman, Daniel J. Sargent, John C. Cheville
International Journal of Radiation Oncology, Biology, Physics. 2007-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: